License and Devlopment Agreement between Genentech, Inc., and SurModics, Inc.License and Development Agreement • February 5th, 2010 • Surmodics Inc • Pharmaceutical preparations • New York
This License and Development Agreement (“Agreement”) is made and entered into as of the 5th day of October, 2009 (the “Effective Date”) by and between SurModics, Inc., a Minnesota corporation with a principal place of business at 9924 West 74th Street, Eden Prairie MN 55344 (together with its Affiliates, “SurModics”), Genentech, Inc., a Delaware corporation, with offices located at 1 DNA Way, South San Francisco, CA 94080 (“GNE”) and F. Hoffmann-La Roche, Ltd., Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche together referred to as “Genentech”). SurModics and Genentech are each referred to herein individually as a “Party” and collectively as the “Parties.”
MASTER SERVICE AGREEMENT by and between Genentech, Inc., and SurModics, Inc.Master Service Agreement • February 5th, 2010 • Surmodics Inc • Pharmaceutical preparations
THIS MASTER SERVICE AGREEMENT (the “MSA”) is entered into as of the 5th day of October 2009 (“Effective Date”) by and between Genentech, Inc., a Delaware corporation, with offices located at 1 DNA Way, South San Francisco, CA 94080 (“GNE”) and F. Hoffmann-La Roche, Ltd., Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche together referred to as “Genentech”) and SurModics, Inc. a Minnesota corporation with a principal place of business at 9924 West 74th Street, Eden Prairie, MN 55344 (SurModics, Inc. together with its Affiliates hereinafter referred to as “SurModics”) (each individually a “Party” and collectively, the “Parties”).
